Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sentinel lymph node for breast cancer: remove less to know more].

L Fortunato1, C Benzoni, M Amini

  • 1Modulo di Chirurgia Oncologica, Ospedale M. G. Vannini, Rome, Italy. lfortunato@tiscalinet.it

Minerva Chirurgica
|September 25, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT study.

Breast (Edinburgh, Scotland)·2026
Same author

Aniridia-associated keratopathy: Clinical and molecular mechanisms of disease progression and emerging therapeutic targets.

Acta ophthalmologica·2026
Same author

The variety and origin of materials accreted by Bennu's parent asteroid.

Nature astronomy·2025
Same author

Veterinary response to non-epidemic disasters: the experience of the Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale" after the 2009 earthquake in L'Aquila, Italy.

New Zealand veterinary journal·2025
Same author

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.

Tumori·2025
Same author

Anti-PD-1 treatment response is associated with the influx of circulating myeloid and T-cell subsets into the metastatic melanoma tumor microenvironment.

British journal of cancer·2025

Sentinel lymph node (SLN) biopsy accurately identifies breast cancer spread, reducing the need for axillary lymphadenectomy in most patients. This minimally invasive technique ensures precise staging while improving patient outcomes.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Diagnostic Imaging

Context:

  • Breast cancer staging is critical for treatment planning.
  • Axillary lymph node status significantly impacts prognosis.
  • Sentinel lymph node biopsy (SLN) is an evolving technique for staging breast cancer.

Purpose:

  • To evaluate the efficacy and reproducibility of sentinel lymph node (SLN) biopsy in a community hospital setting.
  • To determine the value of SLN biopsy in patients with early-stage breast cancer.
  • To assess the potential to reduce routine axillary lymphadenectomy.

Summary:

  • A prospective study of 108 breast cancer patients (tumor <3cm) utilized a combined technetium-99m and Patent Blue dye method for SLN identification.
  • The SLN identification success rate was 94%, with 98% correlation to final axillary status.

Related Experiment Videos

  • In 61% of patients with positive axillary nodes, the SLN was the only positive node; 62% of patients could have avoided axillary dissection based on negative SLN results.

    • Impact:

    • SLN biopsy is a highly accurate and reproducible procedure for breast cancer staging.
    • The findings suggest that routine axillary lymphadenectomy can be avoided in a majority of breast cancer patients.
    • This approach minimizes surgical morbidity and improves patient quality of life.